Source:http://linkedlifedata.com/resource/pubmed/id/10843589
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2000-7-31
|
pubmed:abstractText |
Sampangine (1) is a plant-derived antifungal copyrine alkaloid extracted from the stem bark of Cananga odorata. Although it possesses potent in vitro antifungal activity, 1 is devoid of significant and reproducible in vivo activity in a mouse model of cryptococcosis. Speculating that the lack of in vivo activity could be due to metabolism, a study was undertaken to begin to develop an understanding of the pharmacokinetics, and particularly metabolism of 1. Following intraperitoneal administration of 1 to rats, urine was collected, extracted, and chromatographed over a reversed-phase C(18) silica column to yield the major metabolite, SAM MM1 (2), which was identified by NMR and MS to be an O-glucuronide conjugate of sampangine. In addition, two other unstable, structurally uncharacterized minor metabolites were produced, as evidenced by HPLC analysis. Evaluation of the antifungal and antibacterial activities of 2 showed it to have remarkable in vitro activity against Cryptococcus neoformans.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Alkaloids,
http://linkedlifedata.com/resource/pubmed/chemical/Antifungal Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Glucuronides,
http://linkedlifedata.com/resource/pubmed/chemical/Heterocyclic Compounds with 4 or...,
http://linkedlifedata.com/resource/pubmed/chemical/sampangine
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0163-3864
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
63
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
685-7
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:10843589-Alkaloids,
pubmed-meshheading:10843589-Animals,
pubmed-meshheading:10843589-Antifungal Agents,
pubmed-meshheading:10843589-Bacteria,
pubmed-meshheading:10843589-Biotransformation,
pubmed-meshheading:10843589-Chromatography, High Pressure Liquid,
pubmed-meshheading:10843589-Cryptococcosis,
pubmed-meshheading:10843589-Cryptococcus neoformans,
pubmed-meshheading:10843589-Glucuronides,
pubmed-meshheading:10843589-Heterocyclic Compounds with 4 or More Rings,
pubmed-meshheading:10843589-Magnetic Resonance Spectroscopy,
pubmed-meshheading:10843589-Male,
pubmed-meshheading:10843589-Mass Spectrometry,
pubmed-meshheading:10843589-Mice,
pubmed-meshheading:10843589-Microbial Sensitivity Tests,
pubmed-meshheading:10843589-Rats,
pubmed-meshheading:10843589-Rats, Wistar
|
pubmed:year |
2000
|
pubmed:articleTitle |
Characterization of the major metabolite of sampangine in rats.
|
pubmed:affiliation |
Department of Pharmacognosy, Department of Pharmacology, and National Center for Natural Products Research, Research Institute of Pharmaceutical Sciences, School of Pharmacy, University of Mississippi, 38677, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|